Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 113

1.

An institutional strategy to increase minority recruitment to therapeutic trials.

Anwuri VV, Hall LE, Mathews K, Springer BC, Tappenden JR, Farria DM, Jackson S, Goodman MS, Eberlein TJ, Colditz GA.

Cancer Causes Control. 2013 Oct;24(10):1797-809. doi: 10.1007/s10552-013-0258-1. Epub 2013 Jul 12.

3.

Five National Cancer Institute-designated cancer centers' data collection on racial/ethnic minority participation in therapeutic trials: a current view and opportunities for improvement.

Hawk ET, Habermann EB, Ford JG, Wenzel JA, Brahmer JR, Chen MS Jr, Jones LA, Hurd TC, Rogers LM, Nguyen LH, Ahluwalia JS, Fouad M, Vickers SM.

Cancer. 2014 Apr 1;120 Suppl 7:1113-21. doi: 10.1002/cncr.28571.

5.

Increasing accrual in cancer clinical trials with a focus on minority enrollment: The William Beaumont Hospital Community Clinical Oncology Program Experience.

Vicini F, Nancarrow-Tull J, Shah C, Chmielewski G, Fakhouri M, Sitarek SA, Feczko CT, Brzozowski C, Felten DL.

Cancer. 2011 Oct 15;117(20):4764-71. doi: 10.1002/cncr.26094. Epub 2011 Mar 31.

6.
7.

Impact and costs of targeted recruitment of minorities to the National Lung Screening Trial.

Duda C, Mahon I, Chen MH, Snyder B, Barr R, Chiles C, Falk R, Fishman EK, Gemmel D, Goldin JG, Brown K, Munden RF, Vydareny K, Aberle DR.

Clin Trials. 2011 Apr;8(2):214-23. doi: 10.1177/1740774510396742. Epub 2011 Jan 17.

8.

Assuring access to state-of-the-art care for U.S. minority populations: the first 2 years of the Minority-Based Community Clinical Oncology Program.

Kaluzny A, Brawley O, Garson-Angert D, Shaw J, Godley P, Warnecke R, Ford L.

J Natl Cancer Inst. 1993 Dec 1;85(23):1945-50.

PMID:
8230286
9.

Use of the National Cancer Data Base to develop clinical trials accrual targets that are appropriate for minority ethnicity patients: a report from the American College of Surgeons Oncology Group (ACOSOG) Special Population Committee.

Newman LA, Lee CT, Parekh LP, Stewart AK, Thomas CR Jr, Beltran RA, Lucci A, Green B, Ota D, Nelson H; American College of Surgeons Oncology Group (ACOSOG) Special Population Committee..

Cancer. 2006 Jan 1;106(1):188-95.

10.

State-of-the-science of patient navigation as a strategy for enhancing minority clinical trial accrual.

Ghebre RG, Jones LA, Wenzel JA, Martin MY, Durant RW, Ford JG.

Cancer. 2014 Apr 1;120 Suppl 7:1122-30. doi: 10.1002/cncr.28570. Review.

11.

A surveillance system for monitoring, public reporting, and improving minority access to cancer clinical trials.

Carpenter WR, Tyree S, Wu Y, Meyer AM, DiMartino L, Zullig L, Godley PA.

Clin Trials. 2012 Aug;9(4):426-35. doi: 10.1177/1740774512449531. Epub 2012 Jul 3.

12.

Recruitment of ethnic minorities into cancer clinical trials: experience from the front lines.

Symonds RP, Lord K, Mitchell AJ, Raghavan D.

Br J Cancer. 2012 Sep 25;107(7):1017-21. doi: 10.1038/bjc.2012.240. Epub 2012 May 31. Review.

13.

A report on accrual rates for elderly and minority-ethnicity cancer patients to clinical trials of the American College of Surgeons Oncology Group.

Newman LA, Hurd T, Leitch M, Kuerer HM, Diehl K, Lucci A, Giuliano A, Hunt KK, Putnam W, Wells SA.

J Am Coll Surg. 2004 Oct;199(4):644-51.

PMID:
15454152
14.

The Development of a Minority Recruitment Plan for Cancer Clinical Trials.

Trevino M, Padalecki S, Karnad A, Parra A, Weitman S, Nashawati M, Pollock BH, Ramirez A, Thompson IM.

J Community Med Health Educ. 2013 Sep 1;3(5):1000230.

15.

Enrolling Minority and Underserved Populations in Cancer Clinical Research.

Wallington SF, Dash C, Sheppard VB, Goode TD, Oppong BA, Dodson EE, Hamilton RN, Adams-Campbell LL.

Am J Prev Med. 2016 Jan;50(1):111-7. doi: 10.1016/j.amepre.2015.07.036. Epub 2015 Oct 21.

16.
17.

Cartographic Mapping and Travel Burden to Assess and Develop Strategies to Improve Minority Access to National Cancer Clinical Trials.

Bruner DW, Pugh SL, Yeager KA, Bruner J, Curran W Jr.

Int J Radiat Oncol Biol Phys. 2015 Nov 1;93(3):702-9. doi: 10.1016/j.ijrobp.2015.06.041. Epub 2015 Jul 10.

18.

Recruitment strategy cost and impact on minority accrual to a breast cancer prevention trial.

Dew A, Khan S, Babinski C, Michel N, Heffernan M, Stephan S, Jordan N, Jovanovic B, Carney P, Bergan R.

Clin Trials. 2013 Apr;10(2):292-9. doi: 10.1177/1740774512471452. Epub 2013 Jan 15.

PMID:
23321266
19.

Recruiting minorities where they receive care: Institutional barriers to cancer clinical trials recruitment in a safety-net hospital.

Joseph G, Dohan D.

Contemp Clin Trials. 2009 Nov;30(6):552-9. doi: 10.1016/j.cct.2009.06.009. Epub 2009 Jul 4.

PMID:
19580887
20.

Participation in cancer trials: recruitment of underserved populations.

Paskett ED, Katz ML, DeGraffinreid CR, Tatum CM.

Clin Adv Hematol Oncol. 2003 Oct;1(10):607-13. Review.

PMID:
16258457

Supplemental Content

Support Center